Recent advances in DNA-based molecular devices and their applications in cancer diagnosis

•Functional variability makes DNA-based molecular devices attractive in diagnosis.•Advances in cancer diagnosis applications of DNA-based devices are summarized.•Attention is focused on analysis of cancer biomarkers from a clinical perspective.•Prospects on new frontiers and opportunities in this fi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Coordination chemistry reviews 2023-10, Vol.493, p.215331, Article 215331
Hauptverfasser: Yang, Shuang, Zhu, Ruiwen, Wang, Shuning, Xiong, Yulin, Zhou, Guozhang, Cao, Ya, Zhao, Jing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Functional variability makes DNA-based molecular devices attractive in diagnosis.•Advances in cancer diagnosis applications of DNA-based devices are summarized.•Attention is focused on analysis of cancer biomarkers from a clinical perspective.•Prospects on new frontiers and opportunities in this field are presented. Cancer is one of the leading causes of death worldwide and poses a great threat to human health. In the past few years, diverse molecular devices have been constructed by using DNA molecules as the basic units, such as DNA framework-based molecular devices, DNA walking devices, and DNA biocomputing devices. These molecular devices are endowed to accomplish specific behaviors in chemical and material systems, ranging from simple mechanical motions to complex logic operations. Benefiting from inherent biocompatibility, excellent programmability, and functional variability, DNA-based molecular devices hold great promise in cancer diagnosis and have made impressive progress in this field. Herein, we aim to provide an overview of recent advances in DNA-based molecular devices for cancer diagnosis by highlighting several representative works. Specific attention is focused on the analysis of cancer biomarkers at both in vitro and in vivo scenes. New frontiers and opportunities in this field are also discussed from a clinical perspective.
ISSN:0010-8545
1873-3840
DOI:10.1016/j.ccr.2023.215331